Zobrazeno 1 - 10
of 58
pro vyhledávání: '"B. Mangiarotti"'
Autor:
M.C. Sighinolfi, S. Assumma, E. Morini, A. Del Nero, I. Piacentini, B. Mangiarotti, M. Maggioni, S. Puliatti, S. Picozzi, G. Bozzini, S. Micali, B. Rocco
Publikováno v:
European Urology. 81:S1818
Autor:
M. Piccinelli, E. Morini, Bernardo Rocco, L. Sarchi, M.C. Sighinolfi, B. Mangiarotti, Simone Assumma, A. Del Nero, D. Stroppa, I. Piacentini
Publikováno v:
European Urology Open Science. 33:S124
Publikováno v:
Anti-Cancer Agents in Medicinal Chemistry
Objective: Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) is reported in the literature ranging from 1 to 14.2%. The aim of the present study was to assess the impact on patient’s quality of life and symptoms of Flower pollen extract in
Autor:
Michele Catellani, Stefano Paolo Zanetti, Emanuele Montanari, Andrea Gallioli, Fabrizio Longo, Luca Boeri, Matteo Fontana, B. Mangiarotti
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0170319 (2017)
PLoS ONE
PLoS ONE
The role of rectal culture-guided antimicrobial prophylaxis (TAP) in reducing infectious complications (IC) after transrectal-ultrasound prostate biopsy (TRUSPBx) is conflicting. We assessed the prevalence of IC in a cohort of men at high risk for IC
Autor:
M. Grisotto, Emanuele Montanari, B. Mangiarotti, A. Del Nero, P. Bernardini, S. Confalonieri, F. Marchesotti
Publikováno v:
Urologia Journal. 72:47-49
To determine whether microfocal prostate cancer on needle biopsy predicts clinically insignificant prostate cancer. Patients and Methods We reviewed the records of 257 patients who underwent radical retropubic prostatectomy between January 1999 to Se
Publikováno v:
Urologia Journal. 63:170-187
Incidental carcinoma of the prostate is defined as an incidentally detected cancer without any clinical manifestation, i.e. latent. Clinically, it is diagnosed mostly by TUR and is staged as T1a and T1b according to the TNM classification. There is c
Publikováno v:
Urologia Journal. 71:279-281
Publikováno v:
The Journal of urology. 168(3)
Publikováno v:
Urologia Journal. 59:182-184
From March 1983 to December 1989 we observed 36 patients with metastatic transitional cell carcinoma of the urinary tract. We treated 22 patients with M-VAC regimen and 14 patients with MP regimen. Overall response rate (CR + PR) was 71.4% in M-VAC g
Autor:
A. Del Nero, Emanuele Montanari, A. Currò, D Biasoni, B. Mangiarotti, Nicola Esposito, Enrico Pisani, M. Serrago, G. Zanetti, Alberto Trinchieri
Publikováno v:
European urology. 35(2)
Background: In the present study we compared the clinical value of two new specific tests for transitional cell carcinoma, urinary nuclear matrix protein (NMP22) levels and bladder tumor antigen (BTA) test, with that of urinary cytology in the follow